Abstract
The antiemetic activity, gastric motor activity, and dopamine receptor effects of metoclopramide, dazopride, and sulpiride were assessed to establish if enhancement of gastric motility or antagonism of central dopamine receptors is the predominant action for drug-induced suppression of cisplatin-induced emesis. Emesis produced in dogs by cisplatin is antagonized by metoclopramide and dazopride. The antiemetic actions of metoclopramide and dazopride are associated with their ability to enhance gastric motor activity. Dazopride, unlike metoclopramide, has minimal dopamine receptor antagonist properties. Sulpiride is a potent dopamine receptor antagonist; however, it had no effect on the stomach and was ineffective in suppressing cisplatin-induced emesis.
Similar content being viewed by others
References
Gralla RJ: Metoclopramide: A review of antiemetic trials. Drugs 25(1):63–73, 1983
Harrington RA, Hamilton CW, Brogden RN, Linkewich JA, Romankiewicz JA, Heel RC: Metoclopramide. An updated review of its pharmacological properties and clinical use. Drugs 25(5):451–494, 1983
Akwari OE: The gastrointestinal tract in chemotherapy-induced emesis: A final common pathway. Drugs 25(1):18–34, 1983
Smith WL, Droppleman DA, Gregory RL, Alphin RS: Dazopride (AHR-5531), a novel gastrokinetic agent. Gastroenterology 86(5):1257, 1984
Johnson DN, Dannenburg WN: CNS effects of dazopride (AHR-5531), a new gastrokinetic agent. Gastroenterology 86(5):1126, 1984
Droppleman DA, Gregory RL, Alphin RS: A simplified method for assessing drug effects on gastric emptying in rats. J Pharmacol Methods 4:227–230, 1980
Bass P, Wiley JN: Contractile force transducer for recording muscle activity in unanesthetized animals. J Appl Physiol 32(4):467–570, 1977
Tedeschi DH, Tedeschi RW, Cook L, Mattes PA, Fellows EJ: The neuropharmacology of trifluoperazine: A potent psychotherapeutic agent. Arch Int Pharmacodyn 122:129–143, 1959
Litchfield JT, Wilcoxin F: A simplified method for evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99–113, 1949
Oser BL: Hawk's Physiological Chemistry, 14th ed. New York, McGraw-Hill, 1965, pp 311–313
Lu KH, Amenomori Y, Chen CL, Meites J: Effects of central acting drugs on serum and pituitary prolactin levels in rats. Endocrinology 87:667–672, 1970
Kebabian JW, Calne DB: Multiple receptors for dopamine. Nature 277:93–96, 1979
Creese I, Leff SE: Dopamine receptors: A classification. J Clin Psychopharmacol 2(5):329–335, 1982
Leysen JE, Gommeren W, Laduron PM: Spiperone: A ligand of choice for neuroleptic receptors. Biochem Pharmacol 27:307–316, 1978
Watling KJ, Dowling JE: Dopaminergic mechanisms in the teleoste retina. I. Dopamine sensitive adenylate cyclase in homogenates of carp retina; effects of agonists, antagonists and ergots. J Neurochem 36:559–568, 1981
Brown BL, Albano JDM, Ekins RP, Sgherzi AM: A simple and sensitive saturation assay method for the measurement of adenosine 3′,5′-cyclic monophosphate, Biochem J 121:561–562, 1971
Gylys JA, Doran KM, Buyniski JP: Antagonism of cisplatin induced emesis in the dog. Res Commun Chem Pathol Pharmacol 23(1):61–68, 1979
Iwasaki Y, Kato Y, Chihara K, Ohgo S, Maeda K, Imura H: Effect of sulpiride on plasma prolactin in rats. Neuroendocrinology 21(3):267–274, 1976
Costall B, Naylor RJ: Is there a relationship between the involvement of extrapyramidal and mesolimbic brain areas with the cataleptic action of neuroleptic agents and their clinical antipsychotic effect? Psychopharmacologia 32:161–170, 1973
Borison HL, Wang SC: Physiology and pharmacology of vomiting. Pharmacol Rev 5:193–230, 1953
Borison HL, McCarthy LE: Neuropharmacology of chemotherapy-induced emesis. Drugs 25(1):8–17, 1983
Seigel L, Longo DL: The control of chemotherapy-induced emesis. Ann Intern Med 95(3):352–359, 1981
Laszlo J: Nausea and vomiting as a major complication of cancer chemotherapy. Drugs 25(1):1–7, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Alphin, R.S., Proakis, A.G., Leonard, C.A. et al. Antagonism of cisplatin-induced emesis by metoclopramide and dazopride through enhancement of gastric motility. Digest Dis Sci 31, 524–529 (1986). https://doi.org/10.1007/BF01320319
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01320319